Cannabis: One Year Post Legalization

According to Doug Loe, the approach to investing in the health care and biotechnology sector has always been to focus on the medium and long term. Loe …

Doug Loe Cannabis

© 2020 www.B-TV.com. All Rights Reserved.

Analyst at Echelon Wealth Partners, Doug Loe, speaks about investing the health care and biotechnology sectors after cannabis legalization

According to Doug Loe, the approach to investing in the health care and biotechnology sector has always been to focus on the medium and long term. Loe says, "We are mindful that short term returns are relevant for any diversified portfolio and nascent industries, such as the newly legalized medical cannabis market. This is one that is going to undergo some bumps on profitability as we move forward". Loe believes that there will certainly be some pricing pressure on cannabinoids that have limited intellectual property that is ascribed to the natural products themselves.

This graph shows the number of venture capital cannabis deals in the US and Canada from 2014 to 2019.

You might also like

Canada’s Critical Minerals Push Could Drive the Next Wave of Energy Investment: Lance Mortlock, EY Canada
May 25, 2026

Canada’s Critical Minerals Push Could Drive the Next Wave of Energy Investment: Lance Mortlock, EY Canada

This is some text inside of a div block.
Canada’s Defense Spending Surge Could Reshape Industry Growth: EY Canada
May 25, 2026

Canada’s Defense Spending Surge Could Reshape Industry Growth: Jeff Hamilton, EY Canada

This is some text inside of a div block.
BTV Visits: Calian Group, NevGold, Verdera, Jindalee, & Titan Mining
Metals & Mining
May 25, 2026

BTV Visits: Calian Group, NevGold, Verdera, Jindalee, & Titan Mining

This is some text inside of a div block.
Subscribe and receive the investor Info